These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23395970)
21. Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies. Fornaguera C; Calderó G; Mitjans M; Vinardell MP; Solans C; Vauthier C Nanoscale; 2015 Apr; 7(14):6045-58. PubMed ID: 25766431 [TBL] [Abstract][Full Text] [Related]
22. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
23. Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles. Thasneem YM; Sajeesh S; Sharma CP J Biomed Mater Res A; 2011 Dec; 99(4):607-17. PubMed ID: 21953904 [TBL] [Abstract][Full Text] [Related]
24. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. McCarron PA; Marouf WM; Donnelly RF; Scott C J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271 [TBL] [Abstract][Full Text] [Related]
25. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272 [TBL] [Abstract][Full Text] [Related]
26. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 3: properties of hydroxyapatite nano-rods and investigation of a distribution of the drug within the composite. Vukomanović M; Zavašnik-Bergant T; Bračko I; Skapin SD; Ignjatović N; Radmilović V; Uskoković D Colloids Surf B Biointerfaces; 2011 Oct; 87(2):226-35. PubMed ID: 21723099 [TBL] [Abstract][Full Text] [Related]
27. Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles. Jain D; Athawale R; Bajaj A; Shrikhande S; Goel PN; Gude RP Colloids Surf B Biointerfaces; 2013 Sep; 109():59-67. PubMed ID: 23608470 [TBL] [Abstract][Full Text] [Related]
30. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
31. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
32. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292 [TBL] [Abstract][Full Text] [Related]
33. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
34. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700 [TBL] [Abstract][Full Text] [Related]
35. Chemical composition and topology of poly(lactide-co-glycolide) revealed by pushing MALDI-TOF MS to its limit. Huijser S; Staal BB; Huang J; Duchateau R; Koning CE Angew Chem Int Ed Engl; 2006 Jun; 45(25):4104-8. PubMed ID: 16729334 [No Abstract] [Full Text] [Related]
36. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438 [TBL] [Abstract][Full Text] [Related]
37. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395 [TBL] [Abstract][Full Text] [Related]
38. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Kuo YC; Lin PI; Wang CC Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298 [TBL] [Abstract][Full Text] [Related]
39. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. Yu KH; Rustgi AK; Blair IA J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428 [TBL] [Abstract][Full Text] [Related]
40. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. Na DH; Youn YS; Lee SD; Son MW; Kim WB; DeLuca PP; Lee KC J Control Release; 2003 Oct; 92(3):291-9. PubMed ID: 14568410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]